Literature DB >> 6174164

[Fibroblast interferon therapy in patients with NHL of low-grade malignancy: preliminary results (author's transl)].

U Fink, W Siegert, D Huhn, W Wilmanns, W E Berdel, B Emmerich, H Hutsteiner, I Wüst, J Rastetter, H Theml, G Riethmüller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6174164     DOI： 10.1007/BF00320101

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


× No keyword cloud information.
  5 in total

1.  Clinical staging of chronic lymphocytic leukemia.

Authors:  K R Rai; A Sawitsky; E P Cronkite; A D Chanana; R N Levy; B S Pasternack
Journal:  Blood       Date:  1975-08       Impact factor: 22.113

2.  Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma.

Authors:  T C Merigan; K Sikora; J H Breeden; R Levy; S A Rosenberg
Journal:  N Engl J Med       Date:  1978-12-28       Impact factor: 91.245

3.  Report of the Committee on Hodgkin's Disease Staging Classification.

Authors:  P P Carbone; H S Kaplan; K Musshoff; D W Smithers; M Tubiana
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

4.  Interferon nomenclature.

Authors: 
Journal:  Nature       Date:  1980-07-10       Impact factor: 49.962

5.  Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma.

Authors:  J U Gutterman; G R Blumenschein; R Alexanian; H Y Yap; A U Buzdar; F Cabanillas; G N Hortobagyi; E M Hersh; S L Rasmussen; M Harmon; M Kramer; S Pestka
Journal:  Ann Intern Med       Date:  1980-09       Impact factor: 25.391
  5 in total
  1 in total

1.  Lack of response in nine patients with breast cancer treated with fibroblast interferon.

Authors:  U Bruntsch; G Groos; F J Tigges; P H Hofschneider; W M Gallmeier
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.